Phase IIa trial of diphencyprone in patients with viral warts

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 19 Feb 2019

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Diphencyprone (Primary)
Indications Warts
Focus Proof of concept; Therapeutic Use
Sponsors Hapten Pharmaceuticals

Most Recent Events

22 Jul 2016 Summary of this trial will be presented at the 2016 Summer Meeting of the American Academy of Dermatology (AAD), according to a RXi Pharmaceuticals media release.
07 Jan 2015 New trial record
19 Dec 2014 This phase IIa trial has been completed, according to a RXi Pharmaceuticals media release.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight